Salinomycin inhibits metastatic colorectal cancer growth and interferes with Wnt/β-catenin signaling in CD133(+) human colorectal cancer cells

BACKGROUND: The polyether antibiotic Salinomycin (Sal) is regarded as an inhibitor of cancer stem cells. Its effectiveness on human colorectal cancer (CRC) cells in vitro has been demonstrated before. The aim of this study was to establish a murine model to investigate the effectiveness of Sal in vi...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:BMC Cancer
Hlavní autoři: Klose, Johannes, Eissele, Jana, Volz, Claudia, Schmitt, Steffen, Ritter, Alina, Ying, Shen, Schmidt, Thomas, Heger, Ulrike, Schneider, Martin, Ulrich, Alexis
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2016
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5114842/
https://ncbi.nlm.nih.gov/pubmed/27855654
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-016-2879-8
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky